1.
Br J Haematol
; 196(3): 787-793, 2022 02.
Article
in English
| MEDLINE
| ID: mdl-34611896
Subject(s)
Myeloproliferative Disorders/etiology , Neoplasms, Second Primary/etiology , Poly(ADP-ribose) Polymerase Inhibitors/adverse effects , Cross-Sectional Studies , Female , France/epidemiology , Humans , Male , Myeloproliferative Disorders/diagnosis , Myeloproliferative Disorders/epidemiology , Neoplasms, Second Primary/diagnosis , Neoplasms, Second Primary/epidemiology , Pharmacovigilance , Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use , Retrospective Studies
2.
Int J Cardiol
; 204: 4-5, 2016 Feb 01.
Article
in English
| MEDLINE
| ID: mdl-26649445